Clinical meaning
Palliative care is a specialized approach to care that focuses on improving quality of life for patients facing life-threatening illness through the prevention and relief of suffering. Unlike hospice care, which is specifically for end-of-life, palliative care can be provided alongside curative treatment at any stage of serious illness. The symptom burden in palliative patients is complex and multidimensional, often involving simultaneous management of pain, dyspnea, nausea, delirium, fatigue, and psychological distress. Pain in palliative care is understood through the concept of total pain, encompassing physical, psychological, social, and spiritual dimensions. The World Health Organization (WHO) pain ladder provides a structured approach to analgesia: Step 1 uses non-opioid analgesics (acetaminophen, NSAIDs) for mild pain; Step 2 adds weak opioids (codeine, tramadol) for moderate pain; Step 3 uses strong opioids (morphine, hydromorphone, fentanyl) for severe pain. Adjuvant medications (antidepressants, anticonvulsants, corticosteroids) may be added at any step. Breakthrough pain is defined as transient flares of pain that occur despite around-the-clock analgesia, and breakthrough doses are typically calculated as 10-15 percent of the total 24-hour opioid dose. Dyspnea in palliative patients results from multiple mechanisms: decreased lung compliance, pleural effusions, airway obstruction, anemia, respiratory muscle weakness, and anxiety. Low-dose opioids reduce the perception of breathlessness by decreasing the medullary respiratory center's sensitivity to carbon dioxide without necessarily causing clinically significant respiratory depression. Nausea and vomiting in palliative care arise from multiple pathways: chemoreceptor trigger zone activation (opioids, metabolic derangements), vestibular input, vagal afferent stimulation from the gastrointestinal tract (bowel obstruction, gastroparesis), and cortical inputs (anxiety, anticipatory nausea). Understanding the underlying mechanism guides antiemetic selection. Delirium affects up to 88 percent of patients in the final weeks of life and results from metabolic derangements, medication effects (especially opioids and anticholinergics), infection, organ failure, and brain metastases. Terminal delirium is often irreversible and management focuses on safety and symptom control rather than identifying the cause. The practical nurse plays a critical role in symptom assessment using validated tools, timely medication administration, non-pharmacological comfort measures, and reporting changes in symptom burden to the supervising nurse or physician.